Dear Readers and Contributors,

We are delighted to inform all of you that the National Library of Medicine has approved our application. From now on eNeurologicalSci (eNS) will be cited in PubMed Central (PMC). This means that full-text articles will not just be available on the journal\'s websites, ScienceDirect (<https://www.sciencedirect.com/journal/eneurologicalsci>) and journal-branded site (<http://www.ens-journal.com>), but also in PMC ([http://www.ncbi.nlm.nih.gov/pmc/](http://www.ncbi.nlm.nih.gov/pmc){#ir0015}). Readers will be able to directly search for eNS articles in PubMed. Indexing in PubMed is reserved for journals with a reliable track record of publication and meritorious scientific content. Authors who previously published in *eNS* will have their work (retroactive to the first issue) readily searchable and citable within the world\'s major database for scientific journals. We regard the achievement of this important benchmark as public acknowledgement of the high quality of our journal, aided by the endeavors of our authors, reviewers, and Editorial Board members alike. Indeed, volunteer support is the cornerstone of every *eNS* issue, and the journal could not have thrived without these key individuals, who pledge their often limited time to its success.

So, with the attainment of this benchmark, what\'s next for eNS?

First, we have made changes to our editorial board including the expansion of its range of expertise and diversification of geographical composition. This new *eNS* Editorial Board will be convening in Los Angeles, California (coinciding with the American Academy of Neurology Annual Conference) in late April 2018 to reaffirm our mission and scope, as well as build camaraderie and develop a consensus vision for the next three years. I would like to express my sincerest appreciation to our outgoing editorial board members, especially our hard working Assistant Editors, Dr. Leonardo Bonilha, Dr. Wayne Feng, and Dr. Catrina Robinson, all of whom worked hard to position *eNS* as a viable and increasingly prominent online, open-access journal.

Second, we are developing several new initiatives to make the journal more exciting and responsive to our readership, and this will include strategies to foster successful career development of the next generation of neuroscientists and highlight neurologic education. For instance, we will initiate an annual prize for the most compelling article submitted to *eNS* by a resident or a fellow as first author. The inaugural winner of this prize will be announced at the beginning of 2020 and all articles published in 2018 and 2019 will be eligible. Furthermore, at the 2019 World Congress of Neurology Meeting in Dubai, United Arab Emirates, we will create opportunities for attendees to speak directly with the eNS Editorial team and learn about ways to get their presentations at the 2019 Meeting promptly published in eNS.

Third, as always, our objective for eNS continues to be to publish the very best original articles and reviews across a broad research spectrum of Neuroscience and Neurology, with the potential for grasping mechanisms and informing management of diseases of the human nervous system. The Journal is especially keen to be a venue for papers related to the mission of the World Federation of Neurology (WFN), by considering contributions from basic neuroscience all the way through to community studies by researchers from around the world. Over the next 2 years, we are aiming to publish more comprehensive high quality review articles on contemporary multidisciplinary topics from established scientists who are leaders in their fields. It is our hope that by doing this, eNS will be better able to bring its readers up-to-speed on the most pertinent developments in clinical and translational neuroscience. Researchers who are potentially interested in serving as a Guest Editor for a Special Issue with \~5 papers on a particular topic are hereby invited to submit their proposals to eNS.

Fourth, eNS intends to achieve more rapid publication of all accepted manuscripts. If contributors have a target publication deadline, kindly contact our editorial office with a pre-submission inquiry including justification for speedy publication. This will allow us to selectively initiate an ultra-rapid peer review and production process. Also, society conference proceedings (full articles or abstracts) and expert-consensus clinical practice guidelines will be coming to future editions of eNS, so please stay tuned. Even articles with so called "negative" results - as long as their research questions are important, novel, relevant to our audience, and have appropriate designs will be fully considered. Moreover, *eNS* will continue to leverage its primarily online milieu by facilitating enhanced use of audiovisual technology and social media tools, thereby augmenting the experience of readers, expanding the exposure of articles, and fostering more engagement with our published scientists.

Fifth, eNS will become even more firmly committed to the mission of the "global" mission of WFN, particularly by encouraging and supporting more scholarly contributions from authors in low- and middle- income countries (LMIC) around the world. We will reach out to prospective authors in these countries and highlight them and their work. Of course a frequent barrier to LMIC authors publishing in open access journals is an ability to readily pay for publication costs. To mitigate this challenge, the editorial board has been granted permission by Elsevier to annually waive publication fees for a limited number of highly noteworthy submissions from LMIC accepted for publication. Of note, Elsevier has a separate program that considers individual fee waiver requests on a case-by-case basis, which may be granted in cases of genuine need. Priority for this waiver program is given to contributions by authors from countries eligible for the Research4Life program ([http://www.research4life.org/eligibility/](http://www.research4life.org/eligibility){#ir0020}). It is important that potential contributors realize that publication acceptance in eNS will now not just expose their work to wide networks of neuroscientists, but also to the infinite e-universe. Potential Reviewers should realize that by participating in manuscript reviews for eNS they will be constructively assisting authors from around the world to enhance their manuscripts and further their careers.

Finally, we are already setting our sights on obtaining that all-important figure, the journal impact factor. We are cautiously optimistic that we will be able to achieve this next major benchmark of a journal\'s credibility, sustainability, and rigor, especially since we have observed that overall citation numbers for eNS have been steadily increasing since the publication of its first issue in March 2015. While we are waiting to receive our first impact score, the eNS Editorial Board will continue to focus on tracking submission metrics, new authors, web site usage, and social media attention, all which are key indicators of stakeholder engagement.

In conclusion, I am grateful to the WFN and its dynamic executive committee for giving me the privilege and responsibility of serving as the Editor-in-Chief of this important journal. We will continue to seek the support of all WFN members, as well as all our colleagues in the academic neuroscience community, as eNS embarks on the next phases of its journey towards being a strong and broadly visible worldwide resource for disseminating and synthesizing new knowledge in this exciting field.
